Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 169 to 171 of 171 entries
Sorted by: Best Match Show Resources per page
The hypertrophic chondrocyte: To be or not to be.

Histology and histopathology

Hallett SA, Ono W, Ono N.
PMID: 34137454
Histol Histopathol. 2021 Jun 17;18355. doi: 10.14670/HH-18-355. Epub 2021 Jun 17.

Hypertrophic chondrocytes are the master regulators of endochondral ossification; however, their ultimate cell fates cells remain largely elusive due to their transient nature. Historically, hypertrophic chondrocytes have been considered as the terminal state of growth plate chondrocytes, which are...

Cite
Hallett SA, Ono W, Ono N. The hypertrophic chondrocyte: To be or not to be. Histol Histopathol. 2021;18355doi: 10.14670/HH-18-355.
Hallett, S. A., Ono, W., & Ono, N. (2021). The hypertrophic chondrocyte: To be or not to be. Histology and histopathology, 18355. https://doi.org/10.14670/HH-18-355
Hallett, Shawn A, et al. "The hypertrophic chondrocyte: To be or not to be." Histology and histopathology vol. (2021): 18355. doi: https://doi.org/10.14670/HH-18-355
Hallett SA, Ono W, Ono N. The hypertrophic chondrocyte: To be or not to be. Histol Histopathol. 2021 Jun 17;18355. doi: 10.14670/HH-18-355. Epub 2021 Jun 17. PMID: 34137454; PMCID: PMC8678381.
Copy Download .nbib Format: NLM
The differential expression of perilipin-2 in hepatoblastoma and its association with prognosis.

Histology and histopathology

Azukisawa S, Zheng J, Guo X, Ura H, Niida Y, Itoh T, Yamada S.
PMID: 34477212
Histol Histopathol. 2021 Sep 03;18371. doi: 10.14670/HH-18-371. Epub 2021 Sep 03.

Perilipin-2, a lipid droplet (LD) coating protein, has been found to be involved in cancer progression. However, its role in hepatoblastoma (HB) is undefined. We collected 87 HB samples and the corresponding clinical data. Immunohistochemistry (IHC) staining was performed...

Cite
Azukisawa S, Zheng J, Guo X, et al. The differential expression of perilipin-2 in hepatoblastoma and its association with prognosis. Histol Histopathol. 2021;18371doi: 10.14670/HH-18-371.
Azukisawa, S., Zheng, J., Guo, X., Ura, H., Niida, Y., Itoh, T., & Yamada, S. (2021). The differential expression of perilipin-2 in hepatoblastoma and its association with prognosis. Histology and histopathology, 18371. https://doi.org/10.14670/HH-18-371
Azukisawa, Sadafumi, et al. "The differential expression of perilipin-2 in hepatoblastoma and its association with prognosis." Histology and histopathology vol. (2021): 18371. doi: https://doi.org/10.14670/HH-18-371
Azukisawa S, Zheng J, Guo X, Ura H, Niida Y, Itoh T, Yamada S. The differential expression of perilipin-2 in hepatoblastoma and its association with prognosis. Histol Histopathol. 2021 Sep 03;18371. doi: 10.14670/HH-18-371. Epub 2021 Sep 03. PMID: 34477212.
Copy Download .nbib Format: NLM
Silencing of SETD6 inhibits the tumorigenesis of oral squamous cell carcinoma by inhibiting methylation of PAK4 and RelA.

Histology and histopathology

Huang W, Liu H, Lv T.
PMID: 33710605
Histol Histopathol. 2021 Feb;36(2):229-237. doi: 10.14670/HH-18-327. Epub 2021 Mar 12.

BACKGROUND: Oral squamous cell carcinoma (OSCC) is one of the most comment types of oral malignancies. SET-domain-containing protein 6 (SETD6) was recently identified as an important regulator of multiple signaling pathways through methylating protein substrates. Meanwhile, SETD6 is known...

Cite
Huang W, Liu H, Lv T. Silencing of SETD6 inhibits the tumorigenesis of oral squamous cell carcinoma by inhibiting methylation of PAK4 and RelA. Histol Histopathol. 2021;36(2):229-237doi: 10.14670/HH-18-327.
Huang, W., Liu, H., & Lv, T. (2021). Silencing of SETD6 inhibits the tumorigenesis of oral squamous cell carcinoma by inhibiting methylation of PAK4 and RelA. Histology and histopathology, 36(2), 229-237. https://doi.org/10.14670/HH-18-327
Huang, Wentao, et al. "Silencing of SETD6 inhibits the tumorigenesis of oral squamous cell carcinoma by inhibiting methylation of PAK4 and RelA." Histology and histopathology vol. 36,2 (2021): 229-237. doi: https://doi.org/10.14670/HH-18-327
Huang W, Liu H, Lv T. Silencing of SETD6 inhibits the tumorigenesis of oral squamous cell carcinoma by inhibiting methylation of PAK4 and RelA. Histol Histopathol. 2021 Feb;36(2):229-237. doi: 10.14670/HH-18-327. Epub 2021 Mar 12. PMID: 33710605.
Copy Download .nbib Format: NLM
Showing 169 to 171 of 171 entries